Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloma, Malignant”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06390852
What this trial is testing

Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 35
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Not applicableStudy completedNCT01499147
What this trial is testing

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute LeukemiaChronic Myelogenous Leukemia+8 more
University of Illinois at Chicago 100
Very early researchStudy completedNCT01171092
What this trial is testing

A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

Who this might be right for
Malignant Lymphoma, Stem Cell TypeAutologous Transplant
University of Kansas Medical Center 21
Not applicableStudy completedNCT02140736
What this trial is testing

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnemiaSolid TumorsMalignant Hemopathies+2 more
Hospira, now a wholly owned subsidiary of Pfizer 2,333
Early research (Phase 1)Ended earlyNCT01846429
What this trial is testing

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

Who this might be right for
TumorCancerPain+6 more
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Not applicableLooking for participantsNCT06250595
What this trial is testing

European Rare Blood Disorders Platform (ENROL)

Who this might be right for
AnemiaBone Marrow FailureBleeding Disorder+9 more
Hospital Universitari Vall d'Hebron Research Institute 37,090
Testing effectiveness (Phase 2)Ended earlyNCT00579111
What this trial is testing

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Who this might be right for
Myelodysplastic and Myeloproliferative DisordersAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Baylor College of Medicine 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439123
What this trial is testing

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Not applicableEnded earlyNCT00900068
What this trial is testing

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 9
Not applicableStudy completedNCT00534118
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Roswell Park Cancer Institute 39
Large-scale testing (Phase 3)Study completedNCT00003805
What this trial is testing

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

Who this might be right for
Bone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more
European Organisation for Research and Treatment of Cancer - EORTC 859
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439175
What this trial is testing

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Testing effectiveness (Phase 2)Ended earlyNCT04465760
What this trial is testing

Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy

Who this might be right for
LymphomaMalignant Solid NeoplasmPlasma Cell Myeloma
OHSU Knight Cancer Institute 9
Not applicableLooking for participantsNCT06870760
What this trial is testing

Pre-malignant States to Hematologic Malignancies in Firefighters

Who this might be right for
Clonal Hematopoiesis of Indeterminate PotentialMonoclonal GammopathyNon Hodgkin Lymphoma+3 more
Wake Forest University Health Sciences 300
Post-approval studies (Phase 4)Not Yet RecruitingNCT05545202
What this trial is testing

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

Who this might be right for
Malignant LymphomaMultiple Myeloma
Pharmacosmos A/S 150
Load More Results